Bioweapons

In September 2016 it was announced that German chemical & pharmaceutical giant Bayer agreed to buy US seeds and pesticides corporation Monsanto in a $66 billion takeover deal. If the sides finalize the agreement (which is to be signed by the end of 2017) and regulatory authorities in USA and EU approve it, it will create a «transatlantic monster», the likes of which the world has never seen before. The new company will to a great extent dictate to the whole world what to eat, what medicine to take and how to run agriculture.

Like the Russian president, Mr. Erdogan did not shrink from challenging the existing status-quo, claiming for Ankara the status of leader of the Muslim world. From the point of view of the Western elite, both of these politicians have signed their own death warrants with such declarations.

Last week the U.S. corporation Monsanto, which holds a leading position in the global market of genetically modified organisms (GMOs), reached a licensing agreement with the Broad Institute, Cambridge, USA, on the commercial use of the innovative genome-editing technology CRISPR/Cas9 for agriculture applications. This news has led some experts to